floxuridine has been researched along with Infections, Staphylococcal in 2 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we screened 12,200 small molecules for Sae inhibitors and identified two anti-cancer drugs, streptozotocin (STZ) and floxuridine (FU), as lead candidates for anti-virulence drug development against staphylococcal infections." | 3.88 | The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus. ( Arya, R; Bae, T; Cho, KH; Jeong, H; Kim, KK; Yeo, WS, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandrini, MP | 1 |
| Shannon, O | 1 |
| Clausen, AR | 1 |
| Björck, L | 1 |
| Piskur, J | 1 |
| Yeo, WS | 1 |
| Arya, R | 1 |
| Kim, KK | 1 |
| Jeong, H | 1 |
| Cho, KH | 1 |
| Bae, T | 1 |
2 other studies available for floxuridine and Infections, Staphylococcal
| Article | Year |
|---|---|
Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria.
Topics: Animals; Anti-Bacterial Agents; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB | 2007 |
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Blood Cell Count; Blood G | 2018 |